In some studies, FLCN loss leads to downregulation of genes involved in the TGF-β pathway such as TGF-β2, INHBA, SMAD3 and THBS1, which was proposed to prevent TGF-β tumor suppressor function (Hong et al., 2010b; Cash et al., 2011). The gene discussed is FLCN; the disease is neoplasm.